arrow
E

Emma E. Wolters

department of neurology
H指数:21
被引数:1,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotype

神经发育和神经环境决定了阿尔茨海默病的发病年龄和表型

2025-09-170
OAAI
Validation and test-retest repeatability performance of parametric methods for [11C]UCB-J PET
2022-01-246
OAAI
Genetically identical twins show comparable tau PET load and spatial distribution
BRAIN
IF11.7
2022-01-1214
OAAI
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease

早发性和晚发性阿尔茨海默氏病的新皮层tau病理与血流与认知缺陷之间的差异关联

2022-01-088
OAAI
The Strategic Biomarker Roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update (vol 48, pg 2070, 2021)

阿尔茨海默氏症诊断生物标志物验证的战略生物标志物路线图: 方法学更新 (第48卷,2070页,2021)

2021-09-211
OA
[18F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

[18F]Flortaucipir PET跨症状前和症状携带者的各种MAPT突变

2021-09-0717
OAAI
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease

阿尔茨海默氏病行为变异中tau病理学的异质性分布

2021-04-1316
OAAI
The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update
2021-03-1022
OAAI
In vivo tau pathology is associated with synaptic loss and altered synaptic function

体内tau病理与突触丧失和突触功能改变有关

2021-02-0558
OAAI
Kinetics and 28-day test-retest repeatability and reproducibility of [11C]UCB-J PET brain imaging

[11C] ucb-j PET脑成像的动力学和28天重测重复性和可重复性

2020-10-0816
OAAI
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease (vol 43, pg 871, 2020)
2020-05-091
OAAI
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease

在阿尔茨海默氏病中,区域性 [18F]flortaucipir PET与疾病严重程度的关系比CSF p-tau更密切

2020-04-1431
OAAI